Among these FMGs, we further investigated the role of CPT1A in DLBCL cell proliferation and apoptosis.<h4>Results</h4>The FAMscore effectively distinguished between high- and low-risk DLBCL patients and served as an independent prognostic factor. The gene discussed is CPT1A; the disease is diffuse large B-cell lymphoma.